Bausch & Lomb Corp Cash Flow Statement
BLCO / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 6 fiscal years. All figures from audited SEC 10-K filings.
Bausch & Lomb Corp generated $283M in operating cash flow and negative free cash flow of $66M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income | -$360.0M | -$317.0M | -$260.0M | $6.0M | $182.0M | -$18.0M |
| Depreciation & Amortization | $421.0M | $436.0M | $382.0M | $379.0M | $415.0M | $442.0M |
| Operating Cash Flow | $283.0M | $232.0M | -$17.0M | $345.0M | $873.0M | $522.0M |
| Capital Expenditures | $349.0M | $291.0M | $181.0M | $175.0M | $193.0M | $253.0M |
| Free Cash Flow | -$66.0M | -$59.0M | -$198.0M | $170.0M | $680.0M | $269.0M |
| FCF Margin | -1.3% | -1.2% | -4.8% | 4.5% | 18.1% | 7.9% |